STOCKWATCH
·
Pharmaceuticals
Deals30 Apr 2025, 01:33 pm

Nectar Lifesciences Receives GMP Certification from ANVISA, Brazil for Two Years

AI Summary

Nectar Lifesciences Limited has announced that its Unit Il, located at Village Saidpura Tehsil Dera Bassi, District S. A. S. Nagar (Mohali), Punjab - 140507 - India, has received Certification of Good Manufacturing Practices for Active Pharmaceutical Ingredients from the Ministry of Health, National Health Surveillance Agency (ANVISA), Brazil. The certification is for Ceftazidime pentahydrate and Ceftriaxone disodium hemiheptahydrate (chemical synthesis and sterilization steps). This certification is valid for two years from April 28, 2025.

Key Highlights

  • Nectar Lifesciences Limited's Unit Il receives GMP Certification from ANVISA, Brazil
  • The certification is for Ceftazidime pentahydrate and Ceftriaxone disodium hemiheptahydrate
  • The certification is valid for two years from April 28, 2025
  • The certification covers chemical synthesis and sterilization steps
  • The certification is from the Ministry of Health, National Health Surveillance Agency (ANVISA), Brazil
NECLIFE
Pharmaceuticals
NECTAR LIFESCIENCES LTD.

Price Impact